|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
FY2021
12 months to Jan 31, 2021
|
FY2020
12 months to Jan 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation, amortization and accretion | |||||
| Stock-based compensation | |||||
| Provision for credit losses | |||||
| Donation of common stock to charitable foundation | |||||
| Amortization of deferred commissions | |||||
| Reduction in carrying amount of right-of-use assets | |||||
| Asset impairment | |||||
| Change in fair value of debt conversion and warrant liabilities | |||||
| Change in fair value of contingent consideration | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Deferred commissions | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Accrued employee liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Insurance proceeds for damaged property and equipment | |||||
| Purchase of intangible assets | |||||
| Purchases of short-term investments | |||||
| Sales of short-term investments | |||||
| Maturities of short-term investments | |||||
| Cash paid for acquisition, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of convertible senior notes, net of issuance costs | |||||
| Proceeds from issuance of common stock upon exercise of stock options | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Principal payments on debt | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for tax | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Lapse in restrictions on early exercised common stock options | |||||
| Property and equipment purchases accrued or in accounts payable | |||||
| Purchase of intangible assets included in accrued expenses and other current liabilities | |||||
Loading...